This educational supplement is only available in selected countries and geographies. [geoip-content country=”AT, BE, BG, HR, CY, CZ, DK, EE, FI, DE, GR, HU, IE, IT, LV, LT, LU, MT, NL, PL, PT, RO, SK, SI, CH, ES, SE, GB”]
In this supplement, sponsored by Shockwave Medical:
-
- Marianne Brodmann (Medical University of Graz, Graz, Austria) gives an overview of recent data on Intravascular Lithotripsy (IVL), outlines early experience with the technology, and highlights key features of the new Shockwave M5+ IVL catheter.
- Emiliano Chisci (Ospedale San Giovanni di Dio, Florence, Italy) tells Vascular News that the Shockwave M5+ Intravascular Lithotripsy (IVL) catheter “should be the first-choice treatment” for a narrowed and calcified iliac axis in endovascular aneurysm repair (EVAR) and thoracic endovascular aortic repair (TEVAR) cases, exemplifying in particular the benefits of its extended size matrix.
- Enrique Alejandre-Lafont (Kantonsspital St Gallen, St Gallen, Switzerland) demonstrates how the faster pulsing of the new Shockwave M5+ Intravascular Lithotripsy (IVL) catheter has increased efficacy in challenging chronic limb threatening ischaemia (CLTI) patients.
- Outlining an “extremely challenging” case, Stefano Fazzini (Tor Vergata University, Rome, Italy) details how the Shockwave M5+ Intravascular Lithotripsy (IVL) catheter has made it possible to treat iliac arteries with an antegrade approach from a brachial access.
[/geoip-content]
